These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 21056739)
1. Therapeutic use of immunoglobulins. Stiehm ER; Orange JS; Ballow M; Lehman H Adv Pediatr; 2010; 57(1):185-218. PubMed ID: 21056739 [No Abstract] [Full Text] [Related]
2. Subcutaneous immunoglobulin infusion to treat infants and toddlers with antibody deficiencies. Meth MJ; Rosenthal DW; Bonagura VR Ann Allergy Asthma Immunol; 2010 Aug; 105(2):187-8. PubMed ID: 20674834 [No Abstract] [Full Text] [Related]
3. [Practical comments on the use of immunoglobulins]. Lewandowicz-Uszyńska A; Swierkot J Pol Merkur Lekarski; 2011 Jun; 30(180):448-51. PubMed ID: 21751557 [TBL] [Abstract][Full Text] [Related]
4. The assessment and management of primary antibody deficiency. Empson M; Sinclair J; O'Donnell J; Ameratunga R; Fitzharris P; Steele R; N Z Med J; 2004 Jun; 117(1195):U914. PubMed ID: 15282626 [No Abstract] [Full Text] [Related]
5. New choices for treatment with subcutaneous immunoglobulins. Pleguezuelo DE; Sánchez-Ramón S Med Clin (Barc); 2017 Jan; 148(2):86-90. PubMed ID: 27919413 [No Abstract] [Full Text] [Related]
6. Immunoglobulin Replacement Therapy for Primary Immunodeficiency. Sriaroon P; Ballow M Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Hospital-Based Intravenous Immunoglobulin and Home-Based Self-Administered Subcutaneous Immunoglobulin in Polish Children with Primary Immunodeficiency Diseases. Bal K; Kałuzińska-Parzyszek I; Sobocińska A; Podlecka D; Jerzyńska J; Stelmach I Indian J Pediatr; 2015 Aug; 82(8):768-9. PubMed ID: 25786586 [No Abstract] [Full Text] [Related]
16. Another subcutaneous immune globulin (Cuvitru) for primary immunodeficiency. Med Lett Drugs Ther; 2017 May; 59(1521):e88-e89. PubMed ID: 28520701 [No Abstract] [Full Text] [Related]
17. Update on the use of immunoglobulin in human disease: A review of evidence. Perez EE; Orange JS; Bonilla F; Chinen J; Chinn IK; Dorsey M; El-Gamal Y; Harville TO; Hossny E; Mazer B; Nelson R; Secord E; Jordan SC; Stiehm ER; Vo AA; Ballow M J Allergy Clin Immunol; 2017 Mar; 139(3S):S1-S46. PubMed ID: 28041678 [TBL] [Abstract][Full Text] [Related]
18. [Intravenous immunoglobulins in dermatology]. Nydegger U; Hunziker T Ann Dermatol Venereol; 2002; 129(8-9):1078-81. PubMed ID: 12442118 [No Abstract] [Full Text] [Related]
19. [General indications for and risks of immunoglobulin treatment]. Morell A Krankenpfl J; 1982 Jun; 20(6):8-11. PubMed ID: 6920506 [No Abstract] [Full Text] [Related]
20. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies. Dams ET; van der Meer JW Lancet; 1995 Apr; 345(8953):864. PubMed ID: 7898254 [No Abstract] [Full Text] [Related] [Next] [New Search]